Atlanta, GA 的 套細胞淋巴瘤 臨床試驗
8 項針對 套細胞淋巴瘤 的研究正在 Atlanta（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
招募中3 期
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- 還有 1 項
Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy
招募中2 期
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
DALY II USA/ MB-CART2019.1 for DLBCL
招募中2 期
- Winship Cancer Institute of Emory University, Atlanta
Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma
招募中觀察性研究
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
招募中1 期
- Winship Cancer Institute of Emory University, Atlanta
SynKIR-310 for Relapsed/Refractory B-NHL
招募中1 期
- Winship Cancer Institute of Emory University, Atlanta
Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas
招募中2 期
- Emory University Hospital/Winship Cancer Institute, Atlanta
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Atlanta
其他城市的 套細胞淋巴瘤 試驗
- Houston, TX15 項研究
- Baldwin Park, CA15 項研究
- Durham, NC13 項研究
- Seattle, WA12 項研究
- New York City, NY12 項研究
- Milwaukee, WI12 項研究
- Boston, MA11 項研究
- Nashville, TN11 項研究
- Columbus, OH11 項研究
- Chicago, IL10 項研究
- Rochester, MN9 項研究
- Portland, OR9 項研究
Atlanta 的其他研究
- 癌症（所有類型）49 項研究
- 非小細胞肺癌47 項研究
- 多發性骨髓瘤42 項研究
- 乳癌41 項研究
- 前列腺癌33 項研究
- 急性髓系白血病31 項研究
- 卵巢癌29 項研究
- 大腸直腸癌29 項研究
- 肺癌29 項研究
- 轉移性癌症28 項研究
- 重度憂鬱症25 項研究
- 心臟衰竭25 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。